Zurich, Switzerland | AFP | Two children who received Zolgensma, a gene therapy produced by Swiss drugmaker Novartis to treat spinal muscular atrophy, have died from liver failure, the company said Friday. Health authorities in Russia and Kazakhstan, where the deaths occurred, have been notified along with those in all countries where the treatment is used, Novartis said in an e-mailed statement. The children died five to six weeks after receiving infusions of Zolgensma and […]